Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
July 25, 2022 at 03:55 pm EDT
Share
Farmacias Benavides, S.A.B. de C.V. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was MXN 3,919.81 million compared to MXN 3,531.3 million a year ago. Net loss was MXN 26.17 million compared to MXN 37.92 million a year ago. Basic loss per share from continuing operations was MXN 0.063997 compared to MXN 0.092742 a year ago.
For the six months, sales was MXN 7,855.33 million compared to MXN 7,233.44 million a year ago. Net income was MXN 55.87 million compared to MXN 16.54 million a year ago. Basic earnings per share from continuing operations was MXN 0.136661 compared to MXN 0.040448 a year ago.
Farmacias Benavides SAB de CV is a Mexico-based company primarily engaged in the pharmaceutical and chemical industry. The Company operates a network of over 700 drug stores located nationwide under the Farmacias Benavides name. Through its network of drug stores, it sells a variety prescription and over the counter (OTC) medicines, cosmetics, personal and baby care products and toiletries, as well as it also provides such related services as laboratory samples, home delivery, prescription laboratory, online pharmacy and photo processing services. As of December 31, 2011, the Company owned such subsidiaries as Servicios Operacionales Benavides SA de CV, Benavides de Reynosa SA de CV and Servicios Logisticos Benavides SA de CV, and Fasa Investment Limitada which was its majority shareholder with 85.25% of its interest.
FARMACIAS BENAVIDES, S.A.B. DE C.V. 
